InvestorsHub Logo

Lakersrback

10/05/18 4:52 PM

#13445 RE: vinovista #13444

How can it not be a valid question? When something is used as an adjunctive treatment the efficacy of the add-on is impossible to measure. This is what the kidney doc said. I was to embarrassed to ask questions as my future father in-law has already balled me out for buying CTSO. He had told me to invest and now he says always invest in something with earnings and a divident. Is the refresh 2 a sepsis trial or a cardiac and kidney trial?